Edition:
United Kingdom

Alfresa Holdings Corp (2784.T)

2784.T on Tokyo Stock Exchange

2,599JPY
15 Dec 2017
Change (% chg)

¥17 (+0.66%)
Prev Close
¥2,582
Open
¥2,585
Day's High
¥2,617
Day's Low
¥2,576
Volume
967,300
Avg. Vol
581,361
52-wk High
¥2,617
52-wk Low
¥1,826

Latest Key Developments (Source: Significant Developments)

Alfresa Holdings says merger between units
Monday, 9 May 2016 

Alfresa Holdings Corp <2784.T>: Says its wholly owned Tokyo-based subsidiary Alfresa Corporation to merge a wholly owned Aichi-based subsidiary CS YAKUHIN CO., LTD. . Says Alfresa Corporation to be survival company .Says the merger planned effective on Oct. 1.  Full Article

Alfresa Holdings amends consolidated full-year outlook and raises year-end dividend forecast for FY 2016
Thursday, 28 Apr 2016 

Alfresa Holdings Corp:Says the company lowered the consolidated full-year outlook for revenue to 2,576,000 mln yen from 2,577,000 mln yen for FY ended March 2016.Sees an increased operating profit forecast to 45,200 mln yen from 37,200 mln yen.Sees an increased ordinary profit forecast to 55,400 mln yen from 47,000 mln yen.Sees an increased net profit forecast to 34,600 mln yen from 29,500 mln yen.Sees an increased earnings per share to 157.28 yen from 134.10 yen per share.Comments increased effectivity of business is the main reason for the forecast.It raised year-end dividend forecast to 17 yen per share from 16 yen per share for FY ended March 2016.  Full Article

R&I affirms Alfresa Holdings Corp‘s rating at "A" and stable outlook
Monday, 11 Apr 2016 

Alfresa Holdings Corp:Rating and Investment Information, Inc. (R&I) affirmed Alfresa Holdings's issuer rating at "A".Rating outlook stable.  Full Article

Alfresa Holdings subsidiary to sell stake in sub-subsidiary
Wednesday, 30 Mar 2016 

Alfresa Holdings Corp:Says Tokyo-based subsidiary Alfresa Corporation to sell 20 pct stake respectively in its wholly owned Tokyo-based subsidiary that engaged in specialty pharmaceutical distribution business and drug delivery business, to TOMITA Pharmaceutical and a Hokkaido-based company.Planned effective in last March.  Full Article

Alfresa Holdings announces business transfer between two wholly owned subsidiaries
Friday, 26 Feb 2016 

Alfresa Holdings Corp:Says the co's Hiroshima-based wholly owned subsidiary to transfer ethical pharmaceuticals selling business in Kyushu area to the co's Tokyo-based wholly owned subsidiary Alfresa Corporation effective on July 1.  Full Article

Alfresa Holdings announces change of chairman and president
Friday, 26 Feb 2016 

Alfresa Holdings Corp:Appoints Denroku Ishiguro who is current president of the co as new chairman of the board.Appoints Taizou Kubo as new president of the co to replace Denroku Ishiguro.Changes effective on April 1.  Full Article

Alfresa Holdings raises consolidated full-year outlook for FY 2016
Friday, 5 Feb 2016 

Alfresa Holdings Corp:Says the company raised the consolidated full-year outlook for the FY ending March 2016.Revenue forecast increased to 2,577,000 million yen from 2,526,000 million yen.Operating profit forecast increased to 37,200 million yen from 30,900 million yen.Ordinary profit forecast increased to 47,000 million yen from 40,600 million yen.Net profit forecast increased to 29,500 million yen from 23,800 million yen.Earnings per share forecast increased to 134.10 yen from 108.19 yen.Comments that increased sales revenue is the main reason for the forecast.  Full Article

BRIEF-Alfresa Holdings says merger in units

* Says co's Saitama-based pharmacy operation wholly owned unit will merge with co's Tokyo-based pharmacy operation wholly owned unit on Oct. 1